The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial.
BACKGROUND:Chronic Obstructive Pulmonary Disease (COPD) is a progressive airway disease characterised by neutrophilic airway inflammation or bronchitis. Neutrophilic bronchitis is associated with both bacterial colonisation and lung function decline and is common in exacerbations of COPD. Despite cu...
Main Authors: | Jodie L Simpson, Heather Powell, Katherine J Baines, David Milne, Harvey O Coxson, Philip M Hansbro, Peter G Gibson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4141795?pdf=render |
Similar Items
-
Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD
by: Katherine J. Baines, et al.
Published: (2018-11-01) -
Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
by: Siva R, et al.
Published: (2014-02-01) -
Influence of Age, Past Smoking, and Disease Severity on TLR2, Neutrophilic Inflammation, and MMP-9 Levels in COPD
by: Jodie L. Simpson, et al.
Published: (2013-01-01) -
Efficacy of azithromycin in severe asthma from the AMAZES randomised trial
by: Peter G. Gibson, et al.
Published: (2019-12-01) -
The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
by: Vermeersch K, et al.
Published: (2016-03-01)